
Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Christmas 2025 skywatching guide: What you can see in the night sky on Dec. 25 - 2
What’s your chronotype? Knowing whether you’re a night owl or an early bird could help you do better on tests and avoid scams - 3
Material of Innovativeness: A Survey of \Releasing Your Imaginative Potential\ Online Workmanship Course - 4
Do-It-Yourself Home Style on a Careful spending plan: Imaginative Thoughts and Tasks - 5
Find the Future of Outsourcing: Exploring the Gig Economy
EU delays signing of Mercosur free trade deal
Instructions to Improve Your Mental Exploration with Cutting edge Measurements
Which Film Has the Incomparable Melodic Score?
3 astronauts settle into their new life in orbit | On the International Space Station this week Dec. 1-5, 2025
Everyone knows F1 is for the girls. I wandered into the Las Vegas desert to find out why.
6 Vehicle Rental Administrations: Pick Your Ideal Ride
How C-reactive protein outpaced ‘bad’ cholesterol as leading heart disease risk marker
Sought-After Extravagance Ocean side Objections for a Lovely Escape
Pedal Power: Divulging Well known Bike Brands for Each Cyclist













